InsidersTradesSigma
Lipigon Pharmaceuticals AB: management transactions · Finland · FIN-FSA
FI:lipigon-pharmaceuticals-abSE0017911613FI·FIN-FSAMcap 1M€Healthcare
Browse the full insider trade history of Lipigon Pharmaceuticals AB, a publicly traded company based in Finland. Shares are quoted on FI FI, under the supervision of FIN-FSA. Operating in the Healthcare sector, Lipigon Pharmaceuticals AB has logged 3 public disclosures. Market capitalisation: €909k. The latest transaction was reported on 27 May 2025 — Purchase. Among the most active insiders: Fredrik Lindgren. The full history is accessible without an account.
3
Insider Decl.
0
Thresholds
€145,092
3 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
0.00 €
Analyst consensus
1 analysts0.01 €Target 0.01 €(+567%)0.01 €
Income statement
Net income−32.4 M€0.0% margin
Valuation
P/Book0.1x
Beta0.13
Balance sheet & cash
Market cap909 k€
Free Cash Flow−35.9 M€
Profitability & ownership
ROE-413.9%
ROA-153.4%
% insiders36.4%
% institutions7.9%
Last declaration on 27 May 2025
Declarations3 total
Executives●Purchase32FIN-FSA
€125,36015,120,000 shares@ €0.008313.79% mcap100.0% of flow
BTA (betald tecknad aktie)
FI:A003O967-1·
Ideal exit: 15 Feb 2026 (T+270)
Executives●Purchase42FIN-FSA
€6,036728,000 shares@ €0.00830.66% mcap100.0% of flow
BTA (betald tecknad aktie)
FI:A003O678-1·
Ideal exit: 15 Feb 2026 (T+270)
Executives●Purchase29FIN-FSA
€13,6971,652,000 shares@ €0.00831.51% mcap100.0% of flow
BTA (betald tecknad aktie)
FI:A003O661-2·
Ideal exit: 15 Feb 2026 (T+270)
3 of 3 declarations